Life Sciences
 
Market Trends:
Recent breakthroughs in decoding the human genome and related metabolisms coincide with the urgent need for the increasing health care costs for an aging population. Big Pharma companies are now in a race for creating IP replacing expiring patents on classic drug. The billions of screening tests involved require smart and low cost devices and consumables enabling short throughput times at low cost per test.
Technologies and manufacturing practices from the optical and electronic industries now penetrate this new field at a high pace in different disciplines:
  • In Research Biophotonics :
    Correlated Single photon counting (TCSPC), Fluorescence Lifetime imaging (FLIM), pulsed laser modules, Routing devices, Fluorescence Resonance Energy Transfer (FRET).
  • In Research and Clinical diagnostic routines:
    Micro fluidics for Capillary Electrophoresis; Flow cytometry.
  • In Hight Througput Screening and High Content Screening:
    Micro array optics and Cellular Imaging.
 

Our Response:
Anteryon offers a complete Toolbox of products, design and development capabilities addressing the complexity of this new devices.

Anteryon provides integrated optical solutions for:
Detection, Imaging, wave guiding, laser module based systems, optical interconnections to the macro-environment, and optical networks.

Integration with Anteryon’s precision microstructure components for micro fluidics and biosensor packaging.

Through our close relations with Philips Center of Manufacturing Technologies and Philips Research, located on the High tech Campus in Eindhoven, Anteryon has access to a world class leading innovation platform.

  INQUIRE FOR CUSTOMIZED
SOLUTIONS HERE!